UK markets closed

Aytu BioPharma, Inc. (AYTU)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.06000.0000 (0.00%)
As of 01:00PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. Estimate-0.64-0.06-2.230.5
Low estimate-0.64-0.06-2.230.5
High estimate-0.64-0.06-2.230.5
Year ago EPS-1.93-0.59-5.11-2.23
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. Estimate17.35M21.17M83.55M77.08M
Low estimate17.35M21.17M83.55M77.08M
High estimate17.35M21.17M83.55M77.08M
Year ago salesN/A30.73M107.4M83.55M
Sales growth (year/est)N/A-31.10%-22.20%-7.70%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.63-0.95-0.04-0.25
Actual EPS-1.93-0.59-1.48-0.04
Difference-1.30.36-1.440.21
Surprise %-206.30%37.90%-3,600.00%84.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.64-0.06-2.230.5
7 days ago-0.64-0.06-2.230.5
30 days ago-0.64-0.06-2.230.5
60 days ago-0.64-0.06-2.230.5
90 days ago-0.480.04-2.170.62
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAYTUIndustrySector(s)S&P 500
Current qtr.66.80%N/AN/AN/A
Next qtr.89.80%N/AN/AN/A
Current year56.40%N/AN/AN/A
Next year122.40%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A